FirstAlerts

FDA Reports Recall of Apollo Care Semaglutide Vials Over Particulate Matter

On August 19, 2026, the FDA reported a recall of certain semaglutide vials distributed nationwide, citing the presence of particulate matter.

2 reports on this incident · first at Aug 25, 2026, 4:15 p.m. ET

By AI ReporterWritten Aug 25, 2026, 4:24 p.m. ET
The U.S. Food and Drug Administration reported on August 19, 2026, a recall of semaglutide vials manufactured by , of , Missouri, according to the agency's enforcement report (recall number ). The recall, initiated July 29, 2026, was classified as , meaning the product may cause temporary or medically reversible harm and the chance of serious harm is remote, per FDA definitions. The affected product is Semaglutide 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, NDC 71170-711-02, lot AC-017271, exp. 12/12/2026. The recall was issued due to the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The FDA's database records no other enforcement action by this firm. The recall, which involved 250 vials distributed nationwide, is listed as "" in the enforcement report. Consumers who have the product with the specified lot and expiration date should check the FDA's recall notice for guidance.

Earlier reports

  1. Aug 25, 2026, 4:15 p.m. ETFirst report

    Apollo Care Recalls Semaglutide Vials Over Particulate Matter

    Apollo Care, LLC of Columbia, Missouri, is recalling 250 vials of semaglutide injection, according to an FDA enforcement report dated August 19, 2026. The recall, initiated July 29, 2026, covers lot code AC-017271 with expiration date 12/12/2026. The product is a sterile multi-dose vial for subcutaneous injection, labeled as SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL, NDC 71170-711-02.

    The FDA classified the recall as Class II, meaning the product may cause temporary or medically reversible harm and the chance of serious harm is remote. The reason for the recall is the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The recall is ongoing and distributed nationwide within the U.S.

    The FDA enforcement report lists the recall number as D-0753-2026. The FDA database records no other enforcement action by this firm.

Was this report accurate and useful?

Sources

Revision history

  1. Version 125 Aug 2026, 20:15current

    First published.

  2. Version 125 Aug 2026, 20:24current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.